CD4 and CD8 T-cell responses are unaffected by B-cell-depleting therapies, which may explain why some of these patients have less severe COVID-19 infection, especially if they have been previously vaccinated against COVID-19 and were able to mount some level of active immune response [4,6]. Here, CD8A is linked to COVID-19.